AKT1 and hepatocellular carcinoma: In hepatocellular carcinoma studies, ERIANIN inhibited the activation of the PI3K/AKT pathway and induced apoptosis in hepatocellular carcinoma cells by inhibiting AKT phosphorylation and promoting the expression of the negative regulatory protein PTEN.